Stewart et al. observed that SLFN11-high SCLC tumors have an enriched interferon (IFN) signaling pathway and that SLFN11 expression correlates positively with expression of genes coding immune targets, including PD-L1 (CD274) [40]. Here, IFNA1 is linked to small cell lung carcinoma.